Share this post on:

Product Name: Eps15 antibody [C3], C-term
Applications: WB
Predicted Target Size: 99 kDa (note) (2)
Positive Controls: Raji , K562 , BCL-1
Form Supplied: Liquid
Concentration: 0.83 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: epidermal growth factor receptor pathway substrate 15
Background: This gene encodes a protein that is part of the EGFR pathway. The protein is present at clatherin-coated pits and is involved in receptor-mediated endocytosis of EGF. Notably, this gene is rearranged with the HRX/ALL/MLL gene in acute myelogeneous leukemias. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq]
Synonyms: AF-1P antibody, AF1P antibody, MLLT5 antibody, EPS15 antibody, ALL1 fused gene from chromosome 1 antibody, epidermal growth factor receptor substrate 15 antibody, protein AF-1p antibody, epidermal growth factor receptor pathway substrate 15 antibody
Cellular Localization: Cytoplasm , Cell membrane; Peripheral membrane protein; Cytoplasmic side , Isoform 2: Early endosome membrane; Peripheral membrane protein; Cytoplasmic side
CAS NO: 232931-57-6
Product: Amuvatinib
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human Eps15. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human, Mouse
Conjugation: Unconjugated
Storage Buffer: 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/26629917?dopt=Abstract

Share this post on: